论文部分内容阅读
1996年2月5～8日在美国国立卫生研究院召开了用于预防传染病的核酸疫苗(NAV)及其管理的国际会议,350名科学家、管理人员和制造商参加了会议.会议主要讨论了两个问题:(1)NAV是如何起作用的;(2)NAV是否可用于改进成功疫苗的接种能力以及有助于产生有效的疫苗.现将会议主要内容介绍如下.
The International Conference on the Prevention and Control of Infectious Diseases DNA Vaccine (NAV) and its Management was held at the National Institutes of Health in the United States on February 5-8, 1996 and 350 scientists, managers and manufacturers attended the meeting. Two questions are asked: (1) how NAV works; (2) whether NAV can be used to improve the vaccination of successful vaccines and to help produce an effective vaccine.